Results 171 to 180 of about 30,764 (208)

Vaccine-Elicited Antibody Responses to Influenza A(H3N2) Subclade K

Liping Wang, Samuel J. Nangle, Alejandra Waller-Pulido, K. McMahan, Juliana Pereira, Jayeshbhai Chaudhari, Leland Barrett, Ritobhas Bhowmik, Keith Farrugia, Reima Ramsamooj, Emilia Mia Sordillo, Viviana Simon, Harm van Bakel, Heba H. Mostafa, Andrew Pekosz, Ai‐ris Y. Collier, Dan H. Barouch   +16 more
openalex   +2 more sources

Противовирусное действие циклоферона в зараженных вирусом гриппа A(H3N2) культурах клеток

, 2019
А. Л. Коваленко, С С Григорян, Isaeva Ei, Е. Н. Ветрова   +3 more
openalex   +2 more sources

Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026.

MMWR Morb Mortal Wkly Rep
Maloney P, Reeves EL, Wielgosz K, Price AM, Natarajan K, DeSilva MB, Dascomb K, Klein NP, Tartof SY, Irving SA, Grannis SJ, Ong TC, Weber ZA, Schuster JE, Zerr DM, Michaels MG, Boom JA, Halasa NB, Staat MA, Weinberg GA, House SL, Saade EA, Geffel KM, Gaglani M, Wernli KJ, Murugan V, Martin ET, Bontrager NAB, Kirby MK, Payne AB, Dawood FS, Tannis A, Moline HL, Zhao SK, Adams K, DeCuir J, Olson SM, Chung JR, Lewis N, Flannery B, Reed C, Garg S, Ellington S, CDC Influenza Vaccine Effectiveness Collaborators, CDC Influenza Vaccine Effectiveness Collaborators.   +44 more
europepmc   +1 more source

Links between influenza epidemics, weather characteristics and all-cause mortality in the Czech Republic, 1982-2020. [PDF]

BMC Public Health
Hanzlíková H, Plavcová E, Kyselý J, Kynčl J, Malý M, Urban A.   +5 more
europepmc   +1 more source

Emergence of the novel PA-D27G mutation conferring reduced baloxavir susceptibility in influenza A viruses circulating in China, 2018-2025. [PDF]

Emerg Microbes Infect
Sun B, Sun Y, Wang H, Tang X, Tang W, Mi Y, Shen Z, Xue Q, Lu Y, Zhao X, Ai J, Lu J, Zhang W.   +12 more
europepmc   +1 more source

Estimating influenza A subtype ratios among critical care admissions in England. [PDF]

Epidemiol Infect
Wolmuth-Gordon HS, Elgohari S, Dabrera G, Green RE.   +3 more
europepmc   +1 more source

Elicitation of Protective Immune Responses Against Influenza Virus Following Intranasal Delivery of Fluzone or Flublok Vaccines. [PDF]

Vaccines (Basel)
Uno N, Thomas MH, Caetano C, Ross TM.
europepmc   +1 more source

Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity. [PDF]

Nat Commun
Gopal AB, Lv H, Pholcharee T, Ouyang WO, Teo QW, Luo Y, Tang YS, Luo M, Mok CKP, Wu NC.   +9 more
europepmc   +1 more source

Nomenclature for Tracking of Genetic Variation of Seasonal Influenza Viruses. [PDF]

Influenza Other Respir Viruses
Neher RA, Huddleston J, Bedford T, Lewis NS, Harvey R, Galiano M, Byrne AMP, James S, Smith D, Łuksza M, Ruchnewitz D, Laessig M, Fujisaki S, Watanabe S, Hasegawa H, Hassell N, Wentworth DE, Kondor R, Deng YM, Dapat C, Subbarao K, Barr I.   +21 more
europepmc   +1 more source

Influenza A(H3N2) virus isolations--United States.

MMWR. Morbidity and mortality weekly report, 1983
openaire   +1 more source